March 6 (Reuters) - Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, bringing an end to a dispute between the two companies that escalated into a legal battle last month, Bloomberg News reported on Friday.

Novo and Hims plan to announce a new partnership as soon as Monday, the report said, citing a person familiar with the matter.

(Reporting by Carlos Méndez in Mexico City; Editing by Himani Sarkar)